We are live on
!
Find out more
EAM
Eventide Asset Management Portfolio holdings
AUM
$6.05B
1-Year Est. Return
76.64%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$325M
AUM Growth
–
Cap. Flow
+$311M
Cap. Flow
% of AUM
95.96%
Top 10 Holdings %
Top 10 Hldgs %
23.82%
Holding
94
New
93
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
+$8.15M |
| 2 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$8.08M |
| 3 |
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
|
+$8.06M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
+$7.87M |
| 5 |
CBI
Chicago Bridge & Iron Nv
CBI
|
+$7.84M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.71% |
| 2 | Consumer Discretionary | 15.26% |
| 3 | Industrials | 10.39% |
| 4 | Energy | 7.87% |
| 5 | Technology | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Celldex Therapeutics
CLDX
$3.02B
| $6.22M | 1.92% |
+17,133
| New | +$6.6M |
|
|
AYR
27
DELISTED
Aircastle Ltd
AYR
| $6.18M | 1.9% |
+322,500
| New | +$5.98M |
|
|
SDRL
28
DELISTED
Seadrill Limited Common Stock
SDRL
| $5.89M | 1.81% |
+535
| New | +$6.31M |
|
|
CPN
29
DELISTED
Calpine Corporation
CPN
| $5.8M | 1.79% |
+297,500
| New | +$5.78M |
|
30
NRG Energy
NRG
$28.3B
| $5.55M | 1.71% |
+193,400
| New | +$5.41M |
|
31
Franklin Covey
FC
$243M
| $5.4M | 1.66% |
+271,800
| New | +$5.29M |
|
32
Wabtec
WAB
$49.4B
| $5.39M | 1.66% |
+72,600
| New | +$4.88M |
|
|
AZPN
33
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $5.37M | 1.65% |
+128,500
| New | +$5.37M |
|
|
STKL
34
DELISTED
SunOpta
STKL
| $5.34M | 1.65% |
+534,000
| New | +$5.15M |
|
35
Agios Pharmaceuticals
AGIO
$1.95B
| $5M | 1.54% |
+208,800
| New | +$4.76M |
|
36
ASML
ASML
$634B
| $4.87M | 1.5% |
+52,000
| New | +$4.82M |
|
|
SUNE
37
DELISTED
SUNEDISON, INC COM
SUNE
| $4.87M | 1.5% |
+372,900
| New | +$4.21M |
|
|
PTLA
38
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $4.46M | 1.37% |
+173,300
| New | +$4.21M |
|
|
IPHI
39
DELISTED
INPHI CORPORATION
IPHI
| $4.41M | 1.36% |
+342,100
| New | +$4.38M |
|
40
Acadia Pharmaceuticals
ACAD
$4.55B
| $4.38M | 1.35% |
+175,400
| New | +$4.14M |
|
41
Puma Biotechnology
PBYI
$402M
| $4.36M | 1.34% |
+42,100
| New | +$2.47M |
|
|
STML
42
DELISTED
Stemline Therapeutics, Inc.
STML
| $4.08M | 1.26% |
+208,100
| New | +$5.55M |
|
43
NOV
NOV
$6.93B
| $3.78M | 1.16% |
+52,678
| New | +$3.83M |
|
44
J.M. Smucker
SJM
$13.1B
| $3.74M | 1.15% |
+36,100
| New | +$3.83M |
|
|
LUMO
45
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $3.46M | 1.07% |
+17,478
| New | +$3.11M |
|
46
Crown Castle
CCI
$33.4B
| $3.29M | 1.01% |
+44,800
| New | +$3.32M |
|
47
Costamare
CMRE
$1.87B
| $3.19M | 0.98% |
+174,700
| New | +$3.1M |
|
|
SGMO
48
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $3.02M | 0.93% |
+217,300
| New | +$2.5M |
|
49
Sarepta Therapeutics
SRPT
$1.64B
| $2.89M | 0.89% |
+141,800
| New | +$4.21M |
|
|
SZYM
50
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $2.63M | 0.81% |
+241,200
| New | +$2.37M |
|
Similar funds
HPG
EMPI
RCG
JWBC
AAM
AA
CM
CIS
Eventide Asset Management's Q4 2013 Portfolio in Review
Q4 2013 is the first quarter with a 13F filing on record for Eventide Asset Management, which disclosed 94 positions worth $325M. Its ten largest holdings account for 24% of the portfolio.
Its largest position is MEDIVATION, INC.: 269,600 shares worth $8.6M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, followed by Consumer Discretionary and Industrials.
- Eventide Asset Management's largest Q4 2013 buy was MEDIVATION, INC.: 269,600 shares worth $8.6M.
- Eventide Asset Management's ten largest holdings make up 24% of its $325M portfolio in Q4 2013.
- Eventide Asset Management disclosed 94 positions in Q4 2013, its first 13F filing on record.
Based on Eventide Asset Management's 13F filing for Q4 2013, filed 11 Feb 2014.